Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cyclophosphamide therapy in pediatric multiple sclerosis.
Perceived impact of spasticity is associated with spatial and temporal parameters of gait in multiple sclerosis.
Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography.
Protective effect of tanreqing injection on axon myelin damage in the brain of mouse model for experimental autoimmune encephalomyelitis.
Venocentric Lesions: An MRI Marker of MS?
Prognostic indicators for long-term disability in multiple sclerosis patients.
Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review.
Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc.
JCV test stratifies PML risk in antibody-positive MS
Non-steroidal anti-inflammatory drug indometacin enhances endogenous remyelination.
Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial
Glycoengineering of Interferon-β 1a Improves Its Biophysical and Pharmacokinetic Properties.
Complementary and Alternative Medicine Use and Nutrient Intake Among Individuals with Multiple Sclerosis in the United States.
Functional identification of neural stem cell-derived oligodendrocytes.
Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients.
Harnessing monocyte-derived macrophages to control central nervous system pathologies: No longer 'if' but 'how'
Fatigue and Depression in Children With Demyelinating Disorders.
The Transcription Factor IRF8 Activates Integrin-Mediated TGF-β Signaling and Promotes Neuroinflammation.
Macrophage and NK-mediated killing of precursor-B acute lymphoblastic leukemia cells targeted with a-fucosylated anti-CD19 humanized antibodies.
[Chronic cerebrospinal venous insufficiency--pathophysiology and treament].
Condition-specific preference-based measures: benefit or burden?
Could Intrathymic Injection of Myelin Basic Protein Suppress Inflammatory Response After Co-culture of T Lymphocytes and BV-2 Microglia Cells?
The T3-induced gene KLF9 regulates oligodendrocyte differentiation and myelin regeneration.
Substance Name: MEDI 551
In multiple sclerosis oligoclonal bands connect to peripheral B cell responses.
Pages
« first
‹ previous
…
164
165
166
167
168
169
170
171
172
…
next ›
last »